Influence of foetal inflammation on the development of meconium aspiration syndrome in term neonates with meconium-stained amniotic fluid.
Acute inflammatory reaction
Foetal inflammatory response
Funisitis
Meconium aspiration syndrome
Term neonates
Journal
PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425
Informations de publication
Date de publication:
2019
2019
Historique:
received:
09
01
2019
accepted:
01
05
2019
entrez:
12
6
2019
pubmed:
12
6
2019
medline:
12
6
2019
Statut:
epublish
Résumé
Meconium-stained amniotic fluid is observed in approximately 10-15% of all deliveries; however, only 5% of neonates with meconium-stained amniotic fluid develop meconium aspiration syndrome (MAS). Although foetal distress and subsequent sympathetic stimulation have been considered as the primary upstream events of MAS, this clinical complication sometimes occurs due to other pathologies, such as intraamniotic inflammation. The aim of this study was to investigate whether the incidence of MAS is associated with the presence of funisitis and chorioamnionitis in term neonates with meconium-stained amniotic fluid. Between April 2013 and March 2015, a total of 95 term neonates with meconium-stained amniotic fluid, who were hospitalized at a neonatal intensive care unit, were enrolled in the study. The placenta and umbilical cord were histopathologically examined. Clinical variables and histopathological findings associated with the incidence of MAS were studied. A total of 36 neonates developed MAS. Univariate logistic regression analysis revealed that a heavier birth weight, male sex, 1-min Apgar score ≤ 7, funisitis (but not chorioamnionitis), and elevated acute-phase inflammatory reaction score were associated with increased incidence of MAS (all In neonates with meconium-stained amniotic fluid, funisitis, as well as low 1-min Apgar score and male sex, was identified as an independent variable for MAS development. Intraamniotic inflammation might be involved in the pathological mechanisms of MAS.
Sections du résumé
BACKGROUND
BACKGROUND
Meconium-stained amniotic fluid is observed in approximately 10-15% of all deliveries; however, only 5% of neonates with meconium-stained amniotic fluid develop meconium aspiration syndrome (MAS). Although foetal distress and subsequent sympathetic stimulation have been considered as the primary upstream events of MAS, this clinical complication sometimes occurs due to other pathologies, such as intraamniotic inflammation. The aim of this study was to investigate whether the incidence of MAS is associated with the presence of funisitis and chorioamnionitis in term neonates with meconium-stained amniotic fluid.
METHODS
METHODS
Between April 2013 and March 2015, a total of 95 term neonates with meconium-stained amniotic fluid, who were hospitalized at a neonatal intensive care unit, were enrolled in the study. The placenta and umbilical cord were histopathologically examined. Clinical variables and histopathological findings associated with the incidence of MAS were studied.
RESULTS
RESULTS
A total of 36 neonates developed MAS. Univariate logistic regression analysis revealed that a heavier birth weight, male sex, 1-min Apgar score ≤ 7, funisitis (but not chorioamnionitis), and elevated acute-phase inflammatory reaction score were associated with increased incidence of MAS (all
CONCLUSION
CONCLUSIONS
In neonates with meconium-stained amniotic fluid, funisitis, as well as low 1-min Apgar score and male sex, was identified as an independent variable for MAS development. Intraamniotic inflammation might be involved in the pathological mechanisms of MAS.
Identifiants
pubmed: 31183262
doi: 10.7717/peerj.7049
pii: 7049
pmc: PMC6546081
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e7049Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Am J Obstet Gynecol. 2000 Mar;182(3):675-81
pubmed: 10739529
Am J Obstet Gynecol. 2000 Nov;183(5):1124-9
pubmed: 11084553
Am J Obstet Gynecol. 2001 Jun;184(7):1422-5; discussion 1425-6
pubmed: 11408862
Am J Obstet Gynecol. 2001 Aug;185(2):496-500
pubmed: 11518916
Obstet Gynecol. 2002 May;99(5 Pt 1):731-9
pubmed: 11978280
Pediatr Dev Pathol. 2003 Sep-Oct;6(5):435-48
pubmed: 14708737
Obstet Gynecol Surv. 2005 Jan;60(1):45-56; quiz 73-4
pubmed: 15618919
N Engl J Med. 2005 Sep 1;353(9):909-17
pubmed: 16135835
Pediatrics. 2006 May;117(5):1712-21
pubmed: 16651329
Obstet Gynecol. 2006 Aug;108(2):345-9
pubmed: 16880305
Am J Obstet Gynecol. 1991 Oct;165(4 Pt 1):1010-3
pubmed: 1951504
J Matern Fetal Neonatal Med. 2010 Jul;23(7):617-21
pubmed: 19757331
Early Hum Dev. 2009 Oct;85(10):617-20
pubmed: 19833459
Int J Pediatr. 2012;2012:359571
pubmed: 22164183
J Matern Fetal Neonatal Med. 2012 Nov;25(11):2470-4
pubmed: 22506729
Gend Med. 2012 Aug;9(4):278-86
pubmed: 22763277
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
J Matern Fetal Neonatal Med. 2014 May;27(8):775-88
pubmed: 24028637
J Perinatol. 2014 Mar;34(3):197-202
pubmed: 24457257
Pediatr Int. 2014 Oct;56(5):702-8
pubmed: 24617834
Arch Gynecol Obstet. 2015 Apr;291(4):849-53
pubmed: 25256123
Obstet Gynecol Sci. 2015 Jan;58(1):24-31
pubmed: 25629015
Dis Markers. 2015;2015:981981
pubmed: 25667565
Neonatology. 2015;107(3):225-30
pubmed: 25721501
Ciba Found Symp. 1979;(77):17-38
pubmed: 261758
Am J Obstet Gynecol. 2016 Mar;214(3):366.e1-9
pubmed: 26484777
Pediatr Pulmonol. 2016 Jun;51(6):601-6
pubmed: 26663621
J Pathol Transl Med. 2017 Sep;51(5):488-498
pubmed: 28793392
Acta Paediatr Scand. 1983 Sep;72(5):679-83
pubmed: 6416019
Am J Perinatol. 1993 Mar;10(2):143-5
pubmed: 8476478
Pathol Res Pract. 1996 Nov;192(11):1121-8
pubmed: 9122031
Am J Obstet Gynecol. 1997 May;176(5):967-75
pubmed: 9166153